Opioid Overdose Treatment: Walgreens To Stock FDA-Approved NARCAN Spray


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Walgreens Boots Alliance Inc (NASDAQ:WBA) said over-the-counter (OTC) NARCAN Nasal Spray will be available at Walgreens stores and online as soon as September 5, with nationwide availability on September 7.

The announcement follows the U.S. Food and Drug Administration's (FDA) approval earlier this year.

NARCAN Nasal Spray can reverse the effects of opioids, including fentanyl.

Also, Emergent BioSolutions Inc (NYSE:EBS), the maker of NARCAN Naloxone HCl Nasal Spray, said today that Naloxone 4 mg will be available on shelves nationwide and online beginning in September.

Naloxone counteracts life-threatening depression of the central nervous and respiratory systems, allowing overdose victims to breathe normally again.

"As a leading healthcare company, providing access to OTC naloxone creates an opportunity for bystanders, friends and family members to potentially save a life," said Walgreens chief medical officer Kevin Ban.

Price Action: WBA shares are trading higher by 0.12% at $25.57 on the last check Wednesday.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EquitiesNewsPenny StocksMarketsGeneralBriefs